Literature DB >> 10651420

Mucosal leishmaniasis: quantitative nasal cytology as a marker of disease activity and indicator of healing.

J B Guerreiro1, A A Cruz, A Barral, H A Lessa, H Rocha, E M Carvalho.   

Abstract

Mucosal leishmaniasis (ML) follow-up is based on subjective parameters. Using simplified quantitative cytology of nasal lavages (QNCs), we studied 20 ML patients, 10 patients with cutaneous leishmaniasis (CL), and 10 healthy subjects. Patients with ML were treated with antimony and followed up with otolaryngological examination plus QNCs for 6 months. At the first evaluation, the median total number of cells in ML patients (1,540,000) was greater than that in CL patients (215,000) or that in healthy subjects (250,000). Neutrophils were predominant in ML patients, in contrast to both sets of controls, in whom epithelial cells were more frequent. During treatment, we found a significant reduction in total nasal cell counts in ML patients who were cured, and encountered a switch in predominant cell type. The cytology of 2 patients who did not respond to antimony remained the same. It is therefore possible to detect nasal inflammation in ML patients through QNCs, which may indicate extension of mucosal involvement, providing an objective parameter to monitor therapy.

Entities:  

Mesh:

Year:  2000        PMID: 10651420     DOI: 10.1177/000348940010900117

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  2 in total

1.  Detection of Leishmania in unaffected mucosal tissues of patients with cutaneous leishmaniasis caused by Leishmania (Viannia) species.

Authors:  Roger Adrian Figueroa; Leyder Elena Lozano; Ibeth Cristina Romero; Maria Teresa Cardona; Martin Prager; Robinson Pacheco; Yira Rosalba Diaz; Jair Alexander Tellez; Nancy Gore Saravia
Journal:  J Infect Dis       Date:  2009-08-15       Impact factor: 5.226

2.  A proposed new clinical staging system for patients with mucosal leishmaniasis.

Authors:  Hélio A Lessa; Marcus M Lessa; Luiz Henrique Guimarães; Clara Mônica F Lima; Sergio Arruda; Paulo R Machado; Edgar M Carvalho
Journal:  Trans R Soc Trop Med Hyg       Date:  2012-05-11       Impact factor: 2.184

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.